Column

A major scientific advance is currently overturning our approach to genetic diseases. The method CRISPR-Cas9 permits modifying any sequence of DNA, a property which was recently used to correct a genetic default responsible for Duchenne muscular dystrophy. But the possibility of selectively editing the human genetic blueprint with this revolutionary tool also raises significant ethical questions. Download this column